AbbottPharmaLong
Long Term breakout failed due to news flow but stock is strong to bounce back
Strong fundamentals and healthy balance sheet
Big player in domestic pharma brands
Buy for long term targets of 26k+ in year
Strong fundamentals and healthy balance sheet
Big player in domestic pharma brands
Buy for long term targets of 26k+ in year
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。